Human MDC/CCL22 ELISA Kit

ELISA

For the determination of Human MDC/CCL22(Macrophage-Derived Chemokine) concentrations in serum, plasma and other related biological fluids.

This assay employs the Sandwich enzyme immunoassay technique. Determine the level of Human MDC/CCL22(Macrophage-Derived Chemokine) in the sample. Add standard and sample to the microplate that have been pre-coated with Anti-Human MDC/CCL22(Macrophage-Derived Chemokine) antibody. After incubation, add Biotin-conjugated anti-Human MDC/CCL22(Macrophage-Derived Chemokine) antibody. It is then combined with HRP-conjugated streptavidin to form an immune complex, then incubated and washed to remove unbound enzyme, and then added to the chromogenic substrate TMB to produce a blue color, and converted to the final yellow under the action of acid. Finally, the absorbance (OD) value was measured at 450 nm. The concentration of Human MDC/CCL22(Macrophage-Derived Chemokine) in the sample was proportional to the OD value. The concentration of Human MDC/CCL22(Macrophage-Derived Chemokine) in the sample can be calculated by drawing a standard curve.

37.5 pg/mL

62.5-4000 pg/mL

This kit recognizes Human MDC/CCL22(Macrophage-Derived Chemokine) in samples. No significant cross-reactivity or interference between Human MDC/CCL22(Macrophage-Derived Chemokine) and analogues was observed.

Three different concentrations of samples were detected 20 times on the same board and 20 times on different boards. Within the plate or between the plates, the coefficient of variation is <10%.

A known concentration of the target protein was added to 5 samples which were diluted to different multiples, and a recovery experiment was performed to obtain a recovery range and an average recovery rate.

Store at 2‑8 °C.

This kit is only for scientific research, not for use